Our Competitive Advantages
World Class Biotech Companies
• Companies from the World’s Best Life Sciences Hubs: Boston & USA, UK, Switzerland
• Excellent Management teams (i.e., Pfizer Ex-president, CEO with more than 7 IPOs with x12,…)
• Exit in 4 years as maximum. Nasdaq Pre-IPOs preferred (3 years as maximum to exit)
Co-Investment with a worldwide ecosystem
Co-Investment with companies and individuals worldwide, including well know investors like Trend Investments, Oxbridge,…
Outstanding Track Record of Ecosystem Players
Team/Advisors with more than 20 exits in top companies like Moderna, Inc. and others